Market Overview:
The global mannitol injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for mannitol injections for various applications such as hospital pharmacies, retail pharmacies, and online pharmacies. North America is expected to dominate the global mannitol injection market during the forecast period owing to the presence of key players in this region and rising demand for mannitol injections from hospitals and retail pharmacies.
Product Definition:
Mannitol Injection is a sterile, non-pyrogenic solution of mannitol for injection. Mannitol is a sugar alcohol which occurs naturally in fruits and vegetables. Mannitol Injection is an osmotic diuretic that increases the excretion of urine, edema fluid and electrolytes.
5 g/100mL:
5 g/100mL is the concentration of mannitol in its liquid form. It's used as a drug to treat diarrhea, dysentery, and vomiting due to acute illness or injury. Mannitol injection is also used as an oral antiscorbutic agent and for the treatment of conditions associated with aging such as cognitive impairment, dementia, etc.
10 g/100mL:
10 g/100mL is the maximum quantity of mannitol that can be added to 100 mL of intravenous or oral solution. It has a solubility in water of 0.9g/100mL and is freely soluble in alcohol, chloroform, and ether.
Application Insights:
Based on application, the global mannitol injection market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment dominated the market in 2017 owing to increasing demand for injectable mannitol as an intravenous solution for treating hyperosmolar syndrome. Mannitol injections are also used as a osmotic therapy to treat dehydration caused by diarrhea or other causes of water loss from the body. Thus, rising healthcare expenditure levels coupled with growing awareness about affordable medicines is expected to drive growth over the forecast period.
The retail pharmacy segment is anticipated to witness significant growth during the forecast period due largelyto increasing consumer awareness regarding access to medical care facilities at an affordable cost through this channel. Moreover, high availability of mannitol injections at relatively lower costs comparedto its counterparts in other regions will further propel industry expansion over next eight years (2018-2030).
The online pharmacy sector has witnessed tremendous growth in recent times owing primarilyto increased internet accessibility.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of diabetes and obesity, rising geriatric population, and growing awareness about alternative therapies for diabetes. In addition, presence of major manufacturers such as Pfizer Inc.; Baxter International; Fresenius Kabi has also contributed towards growth in this region.
Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 owing to various factors such as improving economic conditions leading toward increased disposable income resulting into improved healthcare spending by government & private sectors coupled with rapid urbanization & industrialization that have resulted into an increase in demand for mannitol injection over past few years. Moreover, increasing prevalence of type 2 diabetes and favorable reimbursement policies are some other factors contributing toward growth in Asia Pacific region.
Growth Factors:
- Increasing demand for Mannitol Injection in the field of neurology and cardiology
- Rising prevalence of chronic diseases such as diabetes, heart failure, and stroke
- Growing geriatric population susceptible to various chronic diseases
- Technological advancements in Mannitol Injection manufacturing process
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Mannitol Injection Market Research Report
By Type
5 g/100mL, 10 g/100mL, 15 g/100mL, 20 g/100mL, 25 g/100mL
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
B. Braun, Pfizer, Fresenius Kabi, Hospira, Jiangsu Hengrui Medicine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Mannitol Injection Market Report Segments:
The global Mannitol Injection market is segmented on the basis of:
Types
5 g/100mL, 10 g/100mL, 15 g/100mL, 20 g/100mL, 25 g/100mL
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun
- Pfizer
- Fresenius Kabi
- Hospira
- Jiangsu Hengrui Medicine
Highlights of The Mannitol Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5 g/100mL
- 10 g/100mL
- 15 g/100mL
- 20 g/100mL
- 25 g/100mL
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mannitol Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mannitol injection is a medication used to lower blood sugar levels in people with diabetes. Mannitol is a type of sugar that the body can't use, so it enters the bloodstream and helps to lower blood sugar levels.
Some of the major players in the mannitol injection market are B. Braun, Pfizer, Fresenius Kabi, Hospira, Jiangsu Hengrui Medicine.
The mannitol injection market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mannitol Injection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mannitol Injection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mannitol Injection Market - Supply Chain
4.5. Global Mannitol Injection Market Forecast
4.5.1. Mannitol Injection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mannitol Injection Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mannitol Injection Market Absolute $ Opportunity
5. Global Mannitol Injection Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mannitol Injection Market Size and Volume Forecast by Type
5.3.1. 5 g/100mL
5.3.2. 10 g/100mL
5.3.3. 15 g/100mL
5.3.4. 20 g/100mL
5.3.5. 25 g/100mL
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mannitol Injection Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mannitol Injection Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mannitol Injection Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mannitol Injection Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mannitol Injection Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mannitol Injection Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mannitol Injection Demand Share Forecast, 2019-2026
9. North America Mannitol Injection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mannitol Injection Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mannitol Injection Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mannitol Injection Market Size and Volume Forecast by Type
9.7.1. 5 g/100mL
9.7.2. 10 g/100mL
9.7.3. 15 g/100mL
9.7.4. 20 g/100mL
9.7.5. 25 g/100mL
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mannitol Injection Demand Share Forecast, 2019-2026
10. Latin America Mannitol Injection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mannitol Injection Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mannitol Injection Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mannitol Injection Market Size and Volume Forecast by Type
10.7.1. 5 g/100mL
10.7.2. 10 g/100mL
10.7.3. 15 g/100mL
10.7.4. 20 g/100mL
10.7.5. 25 g/100mL
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mannitol Injection Demand Share Forecast, 2019-2026
11. Europe Mannitol Injection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mannitol Injection Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mannitol Injection Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mannitol Injection Market Size and Volume Forecast by Type
11.7.1. 5 g/100mL
11.7.2. 10 g/100mL
11.7.3. 15 g/100mL
11.7.4. 20 g/100mL
11.7.5. 25 g/100mL
11.8. Basis Point Share (PS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mannitol Injection Demand Share, 2019-2026
12. Asia Pacific Mannitol Injection Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mannitol Injection Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mannitol Injection Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mannitol Injection Market Size and Volume Forecast by Type
12.7.1. 5 g/100mL
12.7.2. 10 g/100mL
12.7.3. 15 g/100mL
12.7.4. 20 g/100mL
12.7.5. 25 g/100mL
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mannitol Injection Demand Share, 2019-2026
13. Middle East & Africa Mannitol Injection Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mannitol Injection Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mannitol Injection Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mannitol Injection Market Size and Volume Forecast by Type
13.7.1. 5 g/100mL
13.7.2. 10 g/100mL
13.7.3. 15 g/100mL
13.7.4. 20 g/100mL
13.7.5. 25 g/100mL
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mannitol Injection Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Mannitol Injection Market: Market Share Analysis
14.2. Mannitol Injection Distributors and Customers
14.3. Mannitol Injection Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. B. Braun
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fresenius Kabi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hospira
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Jiangsu Hengrui Medicine
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
